三生制药子公司与东阳光药业达成克立福替尼独家商业化合作

财中社
25 Nov 2024

  财中社11月25日电三生制药(01530)发布公告,旗下子公司沈阳三生与广东东阳光药业达成合作协议,涉及苯磺酸克立福替尼的商业化。根据协议,沈阳三生将获得克立福替尼在中国大陆特定适应症的独家商业化权利,并将向广东东阳光药业支付首付款及相应的研发和销售里程碑付款。

  广东东阳光药业将继续负责克立福替尼的研发、注册和生产等工作。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10